Claims for Patent: 5,997,867

✉ Email this page to a colleague

Summary for Patent: 5,997,867

Title:	Method of using humanized antibody against CD18
Abstract:	Methods of treating patients suffering from, or at risk of developing, a leukocyte mediated disease comprising the administration of humanized antibodies and fragments thereof that bind human CD18 are disclosed.
Inventor(s):	Herman Waldmann, Martin J. Sims, J. Scott Crowe
Assignee:	Cambridge University Technical Services Ltd CUTS
Application Number:	US08/465,313

Details for Patent 5,997,867

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Biogen Inc.	ZINBRYTA	daclizumab	Injection	761029	May 27, 2016	5,997,867	2016-12-07
Biogen Inc.	ZINBRYTA	daclizumab	Injection	761029	May 26, 2017	5,997,867	2016-12-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.